COSCIENS Biopharma Inc. (CSCI) Financials

$3.54

$0.08 (-2.27%)
Last update: 04:00 PM EST
Day's range
$3.51
Day's range
$3.67
$15M$15M$10M$10M$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20MEarning20182018201920192020202020212021202220222023202320242024150%150%100%100%50%50%0%0%-50%-50%-100%-100%-150%-150%-200%-200%Profit Margin
Profit Margin
Revenue
Earnings

CSCI Income statement / Annual

Last year (2024), COSCIENS Biopharma Inc.'s total revenue was $9.13 M, an increase of 27.77% from the previous year. In 2024, COSCIENS Biopharma Inc.'s net income was -$15.31 M. See COSCIENS Biopharma Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $9.13 M $7.14 M $14.57 M $13.49 M $11.86 M $9.86 M $8.51 M $10.28 M $10.17 M $7.69 M
Cost of Revenue $4.86 M $4.21 M $6.02 M $5.28 M $5.88 M $5.69 M $4.00 M $4.50 M $3.21 M $2.62 M
Gross Profit $4.73 M $2.94 M $8.56 M $8.21 M $5.98 M $4.17 M $4.51 M $5.78 M $6.96 M $5.06 M
Gross Profit Ratio 0.52 0.41 0.59 0.61 0.5 0.42 0.53 0.56 0.68 0.66
Research and Development Expenses $8.30 M $2.04 M $1.37 M $3.04 M $1.48 M $1.83 M $1.96 M $1.28 M $683.82 K $450.54 K
General & Administrative Expenses $0.00 $5.59 M $2.73 M $2.54 M $2.57 M $2.26 M $2.20 M $2.26 M $1.63 M $1.82 M
Selling & Marketing Expenses $0.00 $30.52 K $21.78 K $36.96 K $87.08 K $325.53 K $165.60 K $25.53 K $3.22 K $5.49 K
Selling, General & Administrative Expenses $10.45 M $5.53 M $2.87 M $2.58 M $2.66 M $2.59 M $2.37 M $2.28 M $1.63 M $1.82 M
Other Expenses $4.26 M $0.00 $0.00 $162.26 K $181.37 K $199.56 K $87.17 K $108.60 K $180.69 K $177.70 K
Operating Expenses $23.01 M $7.57 M $4.24 M $5.78 M $4.32 M $4.62 M $4.41 M $3.67 M $2.49 M $2.45 M
Cost And Expenses $27.87 M $11.77 M $10.25 M $11.06 M $10.20 M $10.31 M $8.42 M $8.17 M $5.71 M $5.07 M
Interest Income $441.00 K $59.00 K $145.00 K $0.00 $0.00 $0.00 $263.82 K $77.70 K $148.20 K $131.70 K
Interest Expense $129.00 K $136.00 K $143.00 K $119.13 K $137.37 K $154.25 K $35.28 K $50.98 K $27.96 K $38.03 K
Depreciation & Amortization $1.61 M $1.44 M $1.47 M $1.48 M $1.44 M $322.32 K $56.94 K $259.33 K $267.43 K $282.71 K
EBITDA -$13.49 M -$2.84 M $6.14 M $4.18 M $3.04 M $686.84 K -$216.28 K -$29.11 K $4.29 M $3.08 M
EBITDA Ratio -1.48 -0.4 0.42 0.31 0.26 0.07 -0.03 -0 0.42 0.4
Operating Income Ratio -2 -0.65 0.3 0.18 0.14 -0.05 0.01 0.21 0.44 0.34
Total Other Income/Expenses Net $3.06 M $259.00 K $208.00 K $158.65 K -$203.30 K -$420.57 K -$770.40 K -$2.45 M -$473.22 K $146.99 K
Income Before Tax -$15.23 M -$4.37 M $4.53 M $2.59 M $1.46 M -$869.68 K -$676.36 K -$339.42 K $3.99 M $2.76 M
Income Before Tax Ratio -1.67 -0.61 0.31 0.19 0.12 -0.09 -0.08 -0.03 0.39 0.36
Income Tax Expense $84.00 K -$885.00 K $1.08 M -$52.92 K $415.87 K -$2.61 K -$444.70 K $422.63 K $1.30 M -$784.13 K
Net Income -$15.31 M -$3.49 M $3.45 M $2.64 M $1.46 M -$867.07 K -$231.67 K -$762.05 K $2.69 M $3.55 M
Net Income Ratio -1.68 -0.49 0.24 0.2 0.12 -0.09 -0.03 -0.07 0.26 0.46
EPS -5.93 -1.89 2.51 1.69 0.85 -0.48 -0.13 -0.43 2.13 3.38
EPS Diluted -5.93 -1.89 2.5 1.69 0.85 -0.48 -0.13 -0.43 2.13 3.38
Weighted Average Shares Out $2.58 M $1.85 M $1.84 M $1.83 M $1.83 M $1.82 M $1.80 M $1.78 M $1.60 M $1.46 M
Weighted Average Shares Out Diluted $2.58 M $1.85 M $1.85 M $1.85 M $1.84 M $1.82 M $1.80 M $1.78 M $1.68 M $1.54 M
Link